Inonotus obliquus has obvious inhibitory effect on many tumor cells; Prevent metastasis and recurrence of cancer cells, enhance immunity and promote health; It can also cooperate with radiotherapy and chemotherapy for patients with malignant tumors, enhance their tolerance, reduce toxic and side effects, and relieve the unique pain of cancer patients.
WTO tariff number HSK 07 12.39- 1090 classifies Inonotus obliquus as a non-toxic edible fungus. 1955, the Moscow Academy of Medical Sciences declared Inonotus obliquus as an anticancer substance, and the government approved Inonotus obliquus for drug development.